About Smith & Wesson Brands, Inc. - Common Stock (SWBI)
Smith & Wesson Brands Inc is a well-known American manufacturer of firearms and related products, specializing in the design, production, and distribution of a wide range of firearms, including handguns, long guns, and accessories. With a rich heritage and a strong reputation for quality and innovation, the company caters to various customer segments, including law enforcement, military, and civilian markets. In addition to firearms, Smith & Wesson also offers a selection of tools and accessories that enhance the shooting experience, promoting safety and responsible firearm ownership. Through its commitment to craftsmanship and performance, the company has established itself as a prominent player in the firearms industry. Read More
Shares of american firearms manufacturer Smith & Wesson (NASDAQ:SWBI)
jumped 7.7% in the morning session after the company reported better-than-expected second-quarter 2025 results that surpassed analyst expectations for both revenue and earnings. The firearms manufacturer posted revenue of $85.08 million, a 3.7% year-on-year decline but ahead of the consensus forecast of $79.23 million.
Shares of Smith & Wesson Brands are trading higher Friday. The firearms manufacturer reported Q1 financial results that surpassed analyst expectations.
American firearms manufacturer Smith & Wesson (NASDAQ:SWBI) reported Q2 CY2025 results exceeding the market’s revenue expectations, but sales fell by 3.7% year on year to $85.08 million. Its non-GAAP loss of $0.08 per share was 33.3% above analysts’ consensus estimates.
Hitting a new 52-week low can be a pivotal moment for any stock.
These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds.
American firearms manufacturer Smith & Wesson (NASDAQ:SWBI) reported Q2 CY2025 results topping the market’s revenue expectations, but sales fell by 3.7% year on year to $85.08 million. Its non-GAAP loss of $0.08 per share was 33.3% above analysts’ consensus estimates.
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names.
But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.
The performance of consumer discretionary businesses is closely linked to economic cycles. Unfortunately, the industry’s recent performance suggests demand may be fading as
discretionary stocks have pulled back by 6.1% over the past six months. This drawdown is a far cry from the S&P 500’s 5.3% ascent.
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential.
However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
Investors can certainly boost their returns by concentrating on stocks trading between $1 and $10.
However, a disciplined approach is necessary because many of these businesses are speculative and lack the underlying fundamentals to support their prices.
Rock-bottom prices don't always mean rock-bottom businesses.
The stocks we're examining today have all touched their 52-week lows, creating a classic investor's dilemma: bargain opportunity or value trap?
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance.
Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.
Stocks trading near their 52-week lows offer opportunity and higher yields but come with risk. The question is if these three stocks are a buy, sell, or hold?
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how leisure products stocks fared in Q1, starting with Smith & Wesson (NASDAQ:SWBI).
Shares of american firearms manufacturer Smith & Wesson (NASDAQ:SWBI)
fell 19.1% in the afternoon session after the company reported disappointing first quarter 2025 (fiscal Q4) results as its revenue, EPS, and EBITDA fell short of Wall Street's estimates.
